当前位置: X-MOL 学术Alzheimers Dement. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
SV2A PET shows hippocampal synaptic loss in cognitively unimpaired APOE ε4/ε4 homozygotes
Alzheimer's & Dementia ( IF 13.0 ) Pub Date : 2024-10-30 , DOI: 10.1002/alz.14327
Anniina Snellman, Jouni Tuisku, Mikko Koivumäki, Saara Wahlroos, Richard Aarnio, Johan Rajander, Mira Karrasch, Laura L. Ekblad, Juha O. Rinne

INTRODUCTIONWe investigated hippocampal synaptic density using synaptic vesicle 2A positron emission tomography (PET), and its association with amyloid beta (Aβ) and cognitive performance in healthy apolipoprotein E (APOE) ε4 carriers.METHODSSynaptic density was assessed in 46 individuals (APOE ε4/ε4 n = 14; APOE ε3/ε4 n = 16; APOE ε3/ε3 n = 16) with [11C]UCB‐J‐PET standardized uptake value ratios (SUVRs), by using the centrum semiovale as a reference region. Differences in hippocampal [11C]UCB‐J SUVRs were analyzed with analysis of variance (ANOVA) and linear models. Associations among [11C]UCB‐J SUVR, Aβ, hippocampal volume, and cognitive variables were analyzed with Spearman correlation.RESULTSHippocampal synaptic density was different among the APOE groups (PANOVA = 0.016): APOE ε4/ε4 carriers had lower [11C]UCB‐J SUVRs compared to APOE ε3/ε3 (p = 0.013). Hippocampal synaptic density did not correlate with Consortium to Establish a Registry for Alzheimer's Disease (CERAD) total score (rho = −0.052, p = 0.74), Alzheimer's Prevention Initiative Preclinical Cognitive Composite (APCC) score (rho = 0.17, p = 0.28), or [11C]PiB uptake (rho = −0.10, p = 0.50).DISCUSSIONHippocampal synaptic loss emerges early in the AD continuum and is measurable in vivo in cognitively unimpaired high‐risk individuals.Highlights Synaptic density was studied in vivo in healthy older adults using [11C]UCB‐J positron emission tomography. Apolipoprotein E (APOE) ε4/ε4 carriers had lower hippocampal synaptic density compared to APOE ε3/ε3. Synaptic density was not associated with cognitive performance in this population. Hippocampal synaptic alterations occur before clinical symptoms in APOE ε4/ε4 carriers.

中文翻译:


SV2A PET 显示认知未受损的 APOE ε4/ε4 纯合子的海马突触丢失



引言我们使用突触小泡 2A 正电子发射断层扫描 (PET) 研究了海马突触密度,以及它与淀粉样蛋白 β (Aβ) 和健康载脂蛋白 E (APOE) ε4 携带者的认知能力的关联。方法在 46 例个体中评估了对称密度 (APOE ε4/ε4 n = 14;APOE ε3/ε4 n = 16;APOE ε3/ε3 n = 16),具有 [11C]UCB-J-PET 标准化摄取值比 (SUVR),使用半卵圆中心作为参考区域。使用方差分析 (ANOVA) 和线性模型分析海马 [11C]UCB-J SUVR 的差异。使用 Spearman 相关性分析 [11C]UCB-J SUVR 、 Aβ 、海马体积和认知变量之间的关联。结果APOE 组之间的半基突触密度不同 (PANOVA = 0.016):与 APOE ε3/ε3 相比,APOE ε4/ε4 携带者的 [11C]UCB-J SUVR 较低 (p = 0.013)。海马突触密度与建立阿尔茨海默病登记处联盟 (CERAD) 总分 (rho = -0.052,p = 0.74)、阿尔茨海默病预防倡议临床前认知综合 (APCC) 评分 (rho = 0.17,p = 0.28) 或 [11C] PiB 摄取 (rho = -0.10,p = 0.50) 无关。讨论八肢突触丢失出现在 AD 连续体的早期,并且可以在认知未受损的高危个体体内测量。亮点 使用 [11C]UCB-J 正电子发射断层扫描在健康老年人体内研究了突触密度。与 APOE ε3/ε3 相比,载脂蛋白 E (APOE) ε4/ε4 载体的海马突触密度较低。突触密度与该人群的认知表现无关。海马突触改变发生在 APOE ε4/ε4 携带者临床症状之前。
更新日期:2024-10-30
down
wechat
bug